Achilles Therapeutics lands Series B funding
UK-based Achilles Therapeutics, a biopharmaceutical company, has secured 100 million pounds in Series B funding. RA Capital Management led the round. Goodwin's London life sciences practice advised Achilles on the fundraising.
4 September 2019•4 mins read
